as on March 6, 2026 at 9:31 pm IST
Day's Low
Day's High
2.02%
Downside
0.51%
Upside
52 Week's Low
52 Week's High
15.05%
Downside
30.15%
Upside
as on March 6, 2026 at 4:01 pm IST
Market Cap
₹22,438.97 Cr
Return on Equity (ROE)
24.65
PE Ratio (TTM)
42.29
Return on capital employed (ROCE)
29.14
Industry PE ratio
47.65
Beta (LTM)
0.33
P/B Ratio
9.71
Dividend Yield
0.97
PEG Ratio
6.36
Quarterly Earnings Growth YOY
-6.83
EPS (TTM)
29.445
Sector
Healthcare
Book Value
129.96
Technical Analysis
Bearish
View Technical Analysis
as on March 6, 2026 at 4:01 pm IST
Dr Lal in the last 5 years
Lowest (37.51x)
November 16, 2018
Today (42.29x)
March 5, 2026
Industry (47.65x)
March 5, 2026
Highest (95.62x)
November 5, 2020
Today’s Price to Earnings Ratio: 42.29x
Compare market cap, revenue, PE, and other key metrics of Dr Lal with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 22,438.97 | 3.11% | 0.54 | 492 | 2,461 | |
| HOLD | 56,463.60 | 41% | 0.71 | 354 | 5,553 | |
| HOLD | 66,358.58 | 19.85% | 0.59 | 2,216 | 12,964 | |
| BUY | 9,878.09 | 10.96% | 0.65 | 143 | 704 | |
| BUY | 5,963.13 | 4.9% | 0.53 | 90 | 687 |
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
73.91%
Buy
4.35%
Hold
21.74%
Sell
Search interest for Dr Lal Pathlabs Ltd Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Dr Lal.
Dr Lal Pathlabs Ltd’s net profit fell -6.41% since last year same period to ₹90.50Cr in the Q3 2025-2026. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated -39.91% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending December 2025, Dr Lal Pathlabs Ltd has declared dividend of ₹3.50 per share on 30 Jan 2026 - translating a dividend yield of 2.13%.
Read More about DividendsCheck stock indices that include Dr Lal.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 6.07% to 6.94% in Dec 2025 quarter
MF Holding Up
![]()
Mutual Funds have increased holdings from 15.90% to 16.84% in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Fortis Healthcare Ltd has given 228.0% return, outperforming this stock by 191.2%
Against Peers
![]()
In the last 1 year, Fortis Healthcare Ltd has given 42.0% return, outperforming this stock by 35.6%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 53.22% of holdings in Dec 2025 quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 21.86% to 20.29% in Dec 2025 quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, 150.6 Cr → 90.5 Cr (in ₹), with an average decrease of 39.9% per quarter
Price Dip
![]()
In the last 7 days, LALPATHLAB stock has moved down by -4.3%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 755.4 Cr → 684.2 Cr (in ₹), with an average decrease of 9.4% per quarter
| Organisation | Dr Lal Pathlabs Ltd |
| Headquarters | Gurgaon |
| Industry | Healthcare |
| CEO | Arvind Lal |
| E-voting on shares | Click here to vote |
Dr Lal share price today stands at ₹1360 as on at the close of the market. Dr Lal share today touched a day high of ₹1366.9 and a low of ₹1332.5.
Dr Lal touched a 52 week high of ₹1770 and a 52 week low of ₹1155.38. Dr Lal share price today i.e. is closed at ₹1360, which is -23.16% down from its 52 week high and 17.71% up from its 52 week low.
Dr Lal market capitalisation is ₹22,438.97 Cr as on .
To buy Dr Lal shares, you need to follow these steps:
Dr Lal trading volume is 2.73L as on . This means that 2.73L shares of Dr Lal were bought and sold on the stock market during today's trading session.